107183-41-5

Upstream product

• 107183-40-4 (3R,4aR,6R,8aR)-3-Formyl-6-methoxy-4a-(3-methoxy-phenyl)-octahydro-isoquinoline-2-carboxylic acid benzyl ester 
• 107183-38-0 (5aR,8R,9aR,10aR)-8-Methoxy-9a-(3-methoxy-phenyl)-decahydro-oxazolo[3,4-b]isoquinolin-3-one 
• 107183-37-9 Formic acid (5aR,8R,9aR,10aR)-9a-(3-methoxy-phenyl)-3-oxo-decahydro-oxazolo[3,4-b]isoquinolin-8-yl ester 
• 107183-39-1 (3R,4aR,6R,8aR)-3-Hydroxymethyl-6-methoxy-4a-(3-methoxy-phenyl)-octahydro-isoquinoline-2-carboxylic acid benzyl ester 
• 7706-83-4 (E)-3-(3-methoxyphenyl)-2-butenoic acid ethyl ester 
• 107183-36-8 2-(1-3'-methoxyphenylethenyl)-5-hexen-1-ol 
• 107183-35-7 ethyl 2-(1-3'-methoxyphenylethenyl)-5-hexenoate 
• 107206-00-8 N-<2-(1-3'-methoxyphenylethenyl)-5-hexenyl>oxazolidine-2,4-dione 

Relevant academic research and scientific papers

EFFECT OF A-STRAIN. DIASTEREOSELECTIVE SYNTHESIS OF 3,2'-METHYLENE BRIDGED CIS-4a-ARYLDECAHYDROISOQUINOLINE RING SYSTEM VIA N-ACYLIMINIUM ION-POLYENE RING CLOSURE

Diastereoselective synthesis of 3,2'-methylene bridged 6-oxygenated 4a,6-cis-4a,8a-cis-4a-aryldecahydroisoquinoline ring system was achieved by an application of N-acyliminium ion-polyene cyclization at the initial stage.